Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
70%
OVERLAP
BY WEIGHT
59
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
100%
ALSO IN IXJ
IXJ
114
HOLDINGS
55%
ALSO IN XLV
SECTOR DRIFT (XLV minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 15.2% | 10.2% | 10.2% | |
| JOHNSON & JOHNSON | 10.4% | 7.1% | 7.1% | |
| ABBVIE INC | 7.1% | 4.7% | 4.7% | |
| UNITEDHEALTH GROUP INC | 6.8% | 4.5% | 4.5% | |
| MERCK & CO. INC. | 5.3% | 3.8% | 3.8% | |
XLV Overweight Relative to IXJ
| ELI LILLY & CO | 5.0% | |
| JOHNSON & JOHNSON | 3.3% | |
| ABBVIE INC | 2.4% | |
| UNITEDHEALTH GROUP INC | 2.3% | |
| MERCK & CO. INC. | 1.5% | |
| AMGEN INC | 1.0% | |
| CVS CAREMARK CORP | 0.8% | |
| GILEAD SCIENCES INC | 0.8% | |
| ABBOTT LABORATORIES | 0.8% | |
| THERMO FISHER SCIENTIFIC INC | 0.7% |
XLV Underweight Relative to IXJ
| ASTRAZENECA PLC | -3.8% | |
| NOVARTIS AG | -3.7% | |
| NOVO NORDISK A/S-B | -2.0% | |
| GSK PLC | -1.4% | |
| SANOFI-AVENTIS | -1.3% | |
| ESSILOR INTERNATIONAL | -0.8% | |
| HOYA CORP | -0.8% | |
| TAKEDA PHARMACEUTICAL CO LTD | -0.7% | |
| ARGEN-X SE | -0.7% | |
| LONZA GROUP AG-REG | -0.6% |